Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients

De novo malignancies constitute an emerging cause of morbidity after solid organ transplant (SOT), significantly affecting the long-term survival of transplant recipients. Pharmacologic immunosuppression may functionally impair the immunosurveillance in these patients, thereby increasing the risk of...

Full description

Bibliographic Details
Main Authors: Michela Cangemi, Barbara Montico, Damiana A. Faè, Agostino Steffan, Riccardo Dolcetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Oncology
Subjects:
immunosuppressive drugs
solid organ transplant
dendritic cells
cancer
immune cells
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00160/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00160/full

Similar Items